U-NWBO

Q:NWBO - NORTHWEST BIOTHERAPEUTICS INC - https://www.nwbio.com/

05:35:15 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NWBO - Q	not subscribed					0.1601	-0.0054	-3.3	4,589.7	728	503	0.17 0.17162 0.1581	0.3389 0.1411	15:59:59	Aug 06	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQB -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 503

More trades...

Time ET	Ex	Price	Change	Volume
15:59:59	Q	0.1601	-0.0054	672
15:59:59	Q	0.1601	-0.0054	167
15:59:42	Q	0.1618	-0.0037	100
15:59:05	Q	0.1619	-0.0036	10,000
15:58:28	Q	0.16154	-0.00396	100
15:58:26	Q	0.1619	-0.0036	100
15:58:19	Q	0.1619	-0.0036	5,000
15:58:17	Q	0.1619	-0.0036	605
15:57:40	Q	0.1601	-0.0054	5,000
15:57:33	Q	0.16124	-0.00426	2,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2026-08-06 11:58	U:NWBO	News Release200	Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company
2026-07-08 14:24	U:NWBO	News Release200	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax(TM)-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses
2026-07-02 14:17	U:NWBO	News Release200	Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
2026-06-01 08:30	U:NWBO	News Release200	How Advanced Drug Delivery Could Improve Existing Cancer Treatments
2026-05-11 08:30	U:NWBO	News Release200	CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
2026-04-30 12:30	U:NWBO	News Release200	Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
2026-04-21 09:30	U:NWBO	News Release200	Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
2025-11-20 14:40	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
2025-10-24 12:03	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed

Date ET

Symbol

Type

Headline

2026-08-06 11:58

U:NWBO

News Release

Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company

2026-07-08 14:24

U:NWBO

News Release

Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax(TM)-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses